Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
Disease Category: Diabetes Mellitus, Type 2
Location: United States, FL
Do you have Type II Diabetes? Do you have difficulty in controlling your blood sugar levels on your current anti-diabetic medication?
If the answer is yes, you might be suitable to participate in a clinical research study looking at whether an investigational medication is safe and effective in people with Type II Diabetes who are taking Metformin treatment but whose blood sugar levels are not effectively controlled.
The study will last for about 118 weeks and will involve approximately 23 visits to a study center. Suitable participants will receive study-related medication and health assessments at no cost.
Patient Inclusion Criteria:
You might be able to participate in the GRAND-304 Study if you:
- are 18 years of age or older
- have been diagnosed with Type II Diabetes
- have received less than 7 days of medication, or no medication other than Metformin within the past 2 months
- have difficulty in controlling your blood sugar levels
Patient Exclusion Criteria:
- Please see inclusion criteria
Sara McGilvary, CCRC, Vice President
Clinical Research of West Florida, Inc.
2147 NE Coachman Road
Clearwater, FL 33765
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these